The shares of AECOM (NYSE:ACM) started off the last trading session with the price of $36.6 while closing the day with the price of $36.38. The shares of AECOM (NYSE:ACM) Fell -1.03% with the Loss of -0.22 points.
The shares of AECOM (NYSE:ACM) traded with the day volume of 700564 shares whereas its average trading volume is 939.95 Million.
While analyzing the past performance of the stock we can see that the shares of AECOM (NYSE:ACM) Gain 0.61% in the last week while rising 5.45% in the last month. Past quarter performance shows the red light with -4.49%. The semi-annual and annual performance shows 10.04% and 0.86% respectively.
Some critical values of the shares of AECOM (NYSE:ACM) to be discussed here are: the beta which shows the value at 1.69 while Average True Range of AECOM (NYSE:ACM) demonstrate the value at 0.98. The weekly and monthly volatility of the shares of AECOM (NYSE:ACM) are indicated at 1.60% and 2.54%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 51.12.
While studying the financial position of the shares of AECOM (NYSE:ACM), we can see that the Market capitalization of the company is at 5.72 Billion. The shares outstanding for the company is 157.18 Million and the shares float stands at 157.18 Million. The income of the company stand at 474.9 Million while the sales stand at 18.76 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.97, Price to Earnings or P/E is at 12.23, Price to Sales P/S show the value of 0.3, the Return on Asset ROA stood at 0.029 and the Return on Equity ROE depicted at 0.105 while Return on Investment ROI is at 0.082.
Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)
Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) started its previous trading session at $2.03 and closed at $2.02 showing a Rise of 0.5 Percent.
The Company traded with an average Volume of 622.88 Million whereas, its Day Volume stood at 828698.
Looking at the performance of the stock, Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) Gain 4.66% in the last week in its shares price and 20.24% in the last month. Quarterly performance shows a green of 44.29 Percent while Semi-Annual and Annual performances shows a 65.57 and -42.78 percent respectively.
Beta for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) stands at 0 while the ATR (average true range) is at 0.11. The Stock’s Weekly and Monthly Volatility is 6.70% and 6.40% respectively showing a RSI value of 69.47.
While studying the financial position of the shares of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ), we can see that the Market capitalization of the company is at 133.76 Million. The shares outstanding for the company is 66.22 Million and the shares float stands at 61.58 Million.
The Company generated an income of -110600000 and the sales of 97.9 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.68 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1.37 respectively.
The Return on Assets stands at -0.222, ROE shows a value of -1.264 and ROI for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) is -0.26 as of Trailing Twelve Months period.
